ARTICLE | Company News
Regulus Therapeutics Inc, Biogen Idec deal
February 23, 2015 8:00 AM UTC
Regulus received an undisclosed milestone payment from Biogen Idec under the companies’ 2014 deal to identify microRNA biomarkers for multiple sclerosis. The payment was triggered by Regulus meeting q...